Cholangiocarcinoma is a biliary tumor, which not infrequently complicates primary sclerosing
cholangitis. It carries a poor prognosis and, with the exception of carefully selected …

Background Inflammatory bowel disease (IBD) patients may be at risk for nonalcoholic fatty
liver disease (NAFLD) due to chronic inflammation, hepatotoxic drugs, and alteration of the …

BACKGROUND/AIMS: VCH-759 is a non-nucleoside inhibitor of HCV RNA-dependent
polymerase with sub-micromolar IC 50 values versus genotype 1a/1b replicons. METHODS: The …

Chylous ascites refers to the accumulation of lipid-rich lymph in the peritoneal cavity due to
disruption of the lymphatic system secondary to traumatic injury or obstruction. Worldwide, …

Background Clostridium difficile-associated diarrhea (CDAD) is an increasingly important
diagnosis in solid organ transplant recipients, with rising incidence and mortality. We describe …

Background & Aims Hepatic steatosis (HS) seems common in patients infected with human
immunodeficiency virus (HIV). However, the relative effect of HIV, as well as hepatitis C virus (…

Nonalcoholic steatohepatitis (NASH) affects up to 3% of the North American population. It
occurs as a manifestation of the insulin-resistant state and oxidative stress is thought to be a …

BACKGROUND Polycystic ovary disease (PCOS) may be a risk factor for nonalcoholic fatty
liver disease (NAFLD) due to common pathogenetic pathways, including insulin resistance …

Background & Aims Non-invasive diagnostic methods for liver fibrosis predict clinical outcomes
in viral hepatitis and nonalcoholic fatty liver disease (NAFLD). We specifically evaluated …

Objective: HIV-infected patients are at increased risk of nonalcoholic steatohepatitis (NASH).
Vitamin E is recommended for treatment of NASH in the general population. However, its …